HanchorBio's HCB101 receives US FDA Orphan Drug Designation in gastric cancer

STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)

MEDIPOST files IND amendment to start Phase III trial for knee osteoarthritis therapy

Pegasus Laboratories' KBroVet receives full FDA approval for control of seizures associated with IE in dogs

DifGen Pharmaceuticals' Fluorometholone Ophthalmic Suspension, 0.1% receives FDA approval

Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems

Amgen wins European approval for Uplizna in generalised myasthenia gravis

Arctic Therapeutics enrols first patients in Phase IIa trial of AT-004 for acne vulgaris

BillionToOne launches two new add-on liquid biopsy applications for Northstar Select

Iterion Therapeutics reports first patient dosed in clinical study of tegavivint

FDA accepts Takeda's oveporexton NDA with priority review for narcolepsy type 1

Innocan Pharma reports findings from clinical study of LPT-CBD in dogs

Lunai Bioworks starts new oncology collaboration with clinical-stage partner

Median Technologies secures FDA clearance for AI lung cancer screening software

Sanofi's rilzabrutinib receives FDA breakthrough and Japan orphan designations for rare anaemia